Private

We invest in attractively valued companies that operate in an environment comprised of robust demand, limited competition, high barriers to entry, and an abundance of growth opportunities

Pacific Reach Capital manages four buckets of private investments across various industries and life cycle stages, from early-stage ventures to larger, more established businesses.

Investments

  • Private companies, either those in the early-stage life cycle or pre-IPO opportunities
  • Sufficient future earnings power to leverage sales dollars and opportunistically reinvest in the underlying business

Portfolio Components

Maple Corporation
Apollo Neuro
Diamond Therapeutics
ME Therapeutics
LEAA Health
PrimeTime Holdings
Therma
Vesalius Cardiovascular
Book Jane
Next Health
Agrology
Gryphon Digital Mining
Portage CyberTech
U.S. Bitcoin Corp
Niricson
Audigent
Thunderbird Entertainment Group
Atha Energy
Lannister Mining
Nexii Solutions
Damon Motorcycles
Great Canadian Gaming SPV
SWTCH
Hypercharge
The Planting Hope Co.
Beacon
Pipe
Bond Capital
Rise Properties Trust
  • Diversified set of private equity funds with a target net IRR north of 20%
  • Established track records and prudent capital allocation strategies to mitigate downside risk

Portfolio Components

KKR Health Care Strategic Growth Fund II
Wellington Biomedical Innovation II Access
Goldman Sachs Horizon Environment & Climate Solutions I
Safe Harbor Equity Distressed Debt Fund III
Dyal V
H.I.G Advantage Buyout Fund II and H.I.G. Middle Market LBO Fund IV
ICG Strategic Equity Fund IV
Generation IM Sustainable Solutions Fund IV
Northleaf Capital Growth Fund
Northleaf Capital Opportunities Fund
Northleaf Secondary Partners II & III
TPG Tech Adjacencies II
Thoma Bravo XV
Primavera Fund
Insight Partners Fund XI
Vista Equity Partners VIII Access
  • Venture capital funds with attractive risk-adjusted return mandates
  • Early-stage venture firms with significant growth runways operating in sectors with secular tailwinds

Portfolio Components

Active Impact Investments
Predictive Funds III & IV
Noetic Psychedelic Funds I & II
Onsero Therapeutics
  • Hedge funds under active management mandates proven to generate alpha and maximize risk-adjusted absolute returns over the long run
  • Solid track records of consistent outperformance across all market cycles utilizing a highly disciplined approach

Portfolio Components

BloombergSen
MMCAP Canadian Fund
Vision Strategic Opportunity Fund
Citi China HK Fund